Sandra P. Susanibar-Adaniya, MD, discusses the current standard of care for patients with newly diagnosed multiple myeloma.
Sandra P. Susanibar-Adaniya, MD, assistant professor of medicine, University of Pennsylvania, Penn Medicine, discusses the current standard of care for patients with newly diagnosed multiple myeloma.
Advances in the therapeutic landscape of multiple myeloma over the last 2 decades have provided promising results and beneficial outcomes to patients, Susanibar-Adaniya says.
Treatment for patients with newly diagnosed multiple myeloma begins with induction therapy with the goal of reducing the presence of multiple myeloma, followed by consolidation with stem cell transplantation if a patient is fit enough, Susanibar-Adaniya continues. Maintenance therapy is then utilized to preserve any response that has been obtained, and disease management is used in order to maximize the chances for patients to have a good quality of life, Susanibar-Adaniya concludes.